Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free CYCC Stock Alerts $2.00 -0.49 (-19.68%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial Media Cyclacel Pharmaceuticals Stock Price Performance5 Day Performance+47.06%1 Month Performance-8.79%3 Month Performance-10.31%6 Month Performance-77.05%Year-To-Date Performance-25.09%1 Year Performance-74.16% Receive CYCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. CYCC Stock Chart for Saturday, May, 4, 2024 CYCC Chart by TradingView Cyclacel Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$2.49$2.00-19.68%$2.48$1.94562,862 shs$2.64 million05/02/2024$2.65$2.49-6.04%$3.15$2.441.76 million shs$3.29 million05/01/2024$2.12$2.65+25.00%$4.00$1.8917.48 million shs$3.50 million04/30/2024$1.36$2.12+55.88%$2.29$1.7421.31 million shs$2.80 million04/29/2024$1.51$1.36-9.93%$1.45$1.30226,969 shs$1.80 million04/26/2024$1.60$1.50-6.25%$1.56$1.46181,588 shs$1.98 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$2.28$1.60-29.82%$1.99$1.413.47 million shs$2.11 million04/24/2024$1.79$2.28+27.37%$2.35$1.86441,993 shs$3.01 million04/23/2024$1.75$1.79+2.29%$1.85$1.6828,374 shs$2.36 million04/22/2024$1.78$1.75-1.69%$1.93$1.7324,427 shs$2.31 million04/19/2024$1.85$1.79-3.24%$1.95$1.7710,326 shs$2.36 million04/18/2024$1.95$1.85-5.13%$1.96$1.8137,739 shs$2.44 million04/17/2024$1.67$1.95+16.77%$2.09$1.67114,079 shs$2.57 million04/16/2024$1.58$1.67+5.70%$1.72$1.5247,869 shs$2.20 million04/15/2024$1.76$1.58-10.23%$1.84$1.5738,766 shs$2.09 million04/12/2024$1.94$1.77-8.76%$1.91$1.7629,443 shs$2.34 million04/11/2024$2.05$1.94-5.37%$2.05$1.9124,158 shs$2.56 million04/10/2024$2.11$2.05-2.84%$2.11$1.9538,282 shs$2.71 million04/09/2024$2.11$2.11$2.11$2.075,730 shs$2.79 million04/08/2024$2.10$2.11+0.48%$2.14$2.0524,823 shs$2.79 million04/05/2024$2.19$2.10-4.23%$2.21$2.0317,936 shs$2.77 million04/04/2024$2.20$2.19-0.33%$2.19$2.123,794 shs$2.89 million04/03/2024$2.12$2.20+3.77%$2.22$2.0721,546 shs$2.90 million04/02/2024$2.05$2.12+3.41%$2.15$2.0020,139 shs$2.80 million04/01/2024$2.11$2.05-2.84%$2.23$2.0122,065 shs$2.71 million03/29/2024$2.07$2.11+1.93%$2.14$1.9946,138 shs$1.77 million03/28/2024$2.00$2.07+3.50%$2.14$1.9946,092 shs$1.74 million03/27/2024$1.95$2.00+2.56%$2.09$1.9414,688 shs$1.68 million03/26/2024$2.14$1.95-8.88%$2.18$1.86107,917 shs$1.64 million03/25/2024$2.19$2.14-2.19%$2.22$2.0658,529 shs$1.80 million03/22/2024$2.20$2.18-0.91%$2.23$2.0736,693 shs$1.83 million03/21/2024$2.20$2.20$2.28$2.0820,093 shs$1.85 million03/20/2024$2.35$2.20-6.38%$2.33$2.1649,199 shs$1.86 million03/19/2024$2.42$2.35-2.89%$2.54$2.3335,514 shs$1.97 million03/18/2024$2.43$2.42-0.41%$2.59$2.4019,513 shs$2.03 million03/15/2024$2.50$2.43-2.64%$2.58$2.3725,456 shs$2.05 million03/14/2024$2.51$2.50-0.56%$2.61$2.4612,976 shs$2.10 million03/13/2024$2.48$2.51+1.17%$2.68$2.4716,190 shs$2.11 million03/12/2024$2.56$2.48-3.09%$2.59$2.4715,352 shs$2.08 million03/11/2024$2.64$2.56-3.03%$2.73$2.5033,963 shs$2.15 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.03/08/2024$2.49$2.64+6.02%$2.69$2.4942,530 shs$2.22 million03/07/2024$2.37$2.49+5.06%$2.66$2.3854,004 shs$2.09 million03/06/2024$2.59$2.37-8.49%$2.79$2.3067,391 shs$1.99 million03/05/2024$2.70$2.59-4.07%$2.72$2.5525,473 shs$2.18 million03/04/2024$2.90$2.70-6.90%$3.02$2.6451,527 shs$2.27 million03/01/2024$2.56$2.84+10.94%$2.90$2.5080,765 shs$2.39 million02/29/2024$2.71$2.56-5.54%$2.70$2.5132,244 shs$2.15 million02/28/2024$2.72$2.71-0.37%$2.79$2.679,411 shs$2.28 million02/27/2024$2.85$2.72-4.56%$2.80$2.6515,217 shs$2.29 million02/26/2024$2.65$2.85+7.55%$2.86$2.6338,567 shs$2.39 million02/23/2024$2.61$2.65+1.53%$2.70$2.5811,939 shs$2.23 million02/22/2024$2.72$2.61-3.87%$2.81$2.5931,089 shs$2.19 million02/21/2024$2.93$2.72-7.34%$2.83$2.6919,089 shs$2.29 million02/20/2024$2.97$2.93-1.35%$3.08$2.7450,117 shs$2.46 million02/19/2024$2.97$2.97+0.03%$2.98$2.5473,200 shs$2.50 million02/16/2024$2.66$2.96+11.28%$2.98$2.5471,807 shs$2.49 million02/15/2024$2.59$2.66+2.70%$2.69$2.5048,561 shs$2.23 million02/14/2024$2.50$2.59+3.60%$2.70$2.4053,677 shs$2.18 million02/13/2024$2.46$2.50+1.63%$2.51$2.3930,665 shs$2.10 million02/12/2024$2.28$2.46+7.89%$2.50$2.2656,196 shs$2.07 million02/09/2024$2.32$2.28-1.72%$2.35$2.2532,311 shs$1.92 million02/08/2024$2.33$2.32-0.43%$2.38$2.2345,753 shs$1.95 million02/07/2024$2.51$2.33-7.17%$2.51$2.3228,912 shs$1.96 million02/06/2024$2.58$2.51-2.71%$2.74$2.43189,168 shs$2.12 million02/05/2024$2.23$2.58+15.70%$2.58$2.20155,063 shs$2.17 million Related Companies: Clever Leaves Stock Chart Aridis Pharmaceuticals Stock Chart Biophytis Stock Chart NovaBay Pharmaceuticals Stock Chart 60 Degrees Pharmaceuticals Stock Chart Aravive Stock Chart Avenue Therapeutics Stock Chart Onconetix Stock Chart Mustang Bio Stock Chart Agile Therapeutics Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.